(Q47737649)

5 February 2018

title

The use of PWI and DWI measures in the design of "proof-of-concept" stroke trials (English)

1 reference

5 February 2018

author

Alan Barber

1

1 reference

5 February 2018

Geoffrey A. Donnan

5

1 reference

5 February 2018

author name string

Mark W Parsons

2

1 reference

5 February 2018

Patricia M Desmond

3

1 reference

5 February 2018

Donald A Bennett

4

1 reference

5 February 2018

Brian M Tress

6

1 reference

5 February 2018

Stephen M Davis

7

1 reference

5 February 2018

publication date

1 April 2004

1 reference

5 February 2018

published in

Journal of Neuroimaging

1 reference

5 February 2018

volume

14

1 reference

5 February 2018

issue

2

1 reference

5 February 2018

page(s)

123-132

1 reference

5 February 2018

Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2004.TB00228.X

Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2004.TB00228.X

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2004.TB00228.X

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2004.TB00228.X

AMPA receptor antagonist, YM90K, reduces infarct volume in thrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2004.TB00228.X

Why do neuroprotective drugs work in animals but not humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2004.TB00228.X

Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2004.TB00228.X

High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2004.TB00228.X

High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2004.TB00228.X

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2004.TB00228.X

Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2004.TB00228.X

10.1111/J.1552-6569.2004.TB00228.X

21 January 2018

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

15095557

1 reference

5 February 2018